Ann: Imugene doses first patient in HER-Vaxx phase 2 trial, page-5

"Even though it is 68 patients, this Phase 2 recruitment should be significantly faster than Phase 1 given all the sites that will be open to recruiting."

Also oncologists will be keener to put people on the trial, and they can sell it better.

Before it was something like "we are running a trial with a new drug. It's appears to be safe. We have high hopes...".

And now "we are running a trial with a new drug. It appears to be effective and patients on the drug have had no side effects at all etc etc... a complete response blah blah..."